← Leaderboards
Jonathan C Cohen
University Of Texas Sw Med Ctr/Dallas
$9,447,834
Attributed
$11,820,047
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,820,047 · 5
By mechanism
R01$7,472,584 · 3
RL1$3,691,463 · 1
P30$656,000 · 1
Top collaborators
- Helen H. Hobbs8 shared
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Joyce J Repa$3,001,471
- Christopher B Newgard$30,587,994
- Jeffrey D Browning$4,003,878
- Peter John Espenshade$14,189,166
- Jeff L Browning$117,752
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesPhenotypeHeartGeneticVariantPredispositionSamplingPathway InteractionsMetabolicMolecularResearch PersonnelGenome Wide Association StudyPopulation BasedLipidsBaseLiverPathogenesisFatty LiverProteinsGenotypePrevalenceGrantPreventionHuman Genetics
Grant awards (25)
PNPLA3 in Susceptibility and Resistance to Fatty Liver Disease$575,584
R01 · FY2025 · DK
CORE 4 - Genetics, Single Cell Sequencing and RNA seq Core$164,000
P30 · FY2025 · DK · contact PI
PNPLA3 in Susceptibility and Resistance to Fatty Liver Disease$552,559
R01 · FY2024 · DK
CORE 4 - Genetics, Single Cell Sequencing and RNA seq Core$164,000
P30 · FY2024 · DK · contact PI
PNPLA3 in Susceptibility and Resistance to Fatty Liver Disease$575,584
R01 · FY2023 · DK
CORE 4 - Genetics, Single Cell Sequencing and RNA seq Core$164,000
P30 · FY2023 · DK · contact PI
Genetic and Metabolic Basis of Fatty Liver Disease$608,140
R01 · FY2022 · DK
CORE 4 - Genetics, Single Cell Sequencing and RNA seq Core$164,000
P30 · FY2022 · DK · contact PI
Genetic and Metabolic Basis of Fatty Liver Disease$608,140
R01 · FY2021 · DK
Genetic and Metabolic Basis of Fatty Liver Disease$608,140
R01 · FY2020 · DK
Genetic and Metabolic Basis of Fatty Liver Disease$608,140
R01 · FY2019 · DK
Genetic and Metabolic Basis of Fatty Liver Disease$608,140
R01 · FY2018 · DK
Genetic Susceptibility to Adverse Metabolic Consequences of Obesity$715,920
RL1 · FY2011 · HL · contact PI
Genetic Determinants of Coronary Atherosclerosis$392,500
R01 · FY2011 · HL · contact PI
Genetic Susceptibility to Adverse Metabolic Consequences of Obesity$738,293
RL1 · FY2010 · HL · contact PI
Genetic Determinants of Coronary Atherosclerosis$392,500
R01 · FY2010 · HL · contact PI
Genetic Susceptibility to Adverse Metabolic Consequences of Obesity$745,750
RL1 · FY2009 · HL · contact PI
Genetic Determinants of Coronary Atherosclerosis$392,500
R01 · FY2009 · HL · contact PI
Genetic Susceptibility to Adverse Metabolic Consequences of Obesity$745,750
RL1 · FY2008 · HL · contact PI
Genetic Determinants of Coronary Atherosclerosis$392,500
R01 · FY2008 · HL · contact PI
Genetic Susceptibility to Adverse Metabolic Consequences of Obesity$745,750
RL1 · FY2007 · HL · contact PI
Genetic Determinants of Coronary Atherosclerosis$392,500
R01 · FY2007 · HL · contact PI
GENETIC DETERMINANTS OF PLASMA LIPOPROTEINS$262,799
R01 · FY2002 · HL
GENETIC DETERMINANTS OF PLASMA LIPOPROTEINS$255,144
R01 · FY2001 · HL
GENETIC DETERMINANTS OF PLASMA LIPOPROTEINS$247,714
R01 · FY2000 · HL